SCHEMBL2174032

SCHEMBL2174032

CCC(Oc1cccc2c(S(=O)(=O)NC(=O)Nc3ncc(Br)s3)cn(C)c12)C(=O)O

nearest known ligand 0.75

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
FBP1 P09467 20/20 0.75

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3156546 0.88 FBP1 (0.84) FBP1
SCHEMBL2932042 0.87 FBP1 (0.82) FBP1
SCHEMBL2178259 0.86 FBP1 (1.00) FBP1
SCHEMBL2175253 0.85 FBP1 (0.80) FBP1
SCHEMBL2178055 0.84 FBP1 (1.00) FBP1
SCHEMBL2174038 0.84 FBP1 (0.80) FBP1
SCHEMBL2176079 0.84 FBP1 (0.86) FBP1
SCHEMBL2175098 0.83 FBP1 (0.55) FBP1
SCHEMBL2176373 0.82 FBP1 (0.83) FBP1
SCHEMBL2175610 0.82 FBP1 (0.79) FBP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7973051-B2 Aminothiazoles as FBPase inhibitors for diabetes HOFFMAN-LA ROCHE INC. (US) 2011-07-05 US claimed
US-7973051-B2 Aminothiazoles as FBPase inhibitors for diabetes HOFFMAN-LA ROCHE INC. (US) 2011-07-05 US disclosed